vendredi 31 décembre 2021

Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision

Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.

from NYT > Health https://ift.tt/3qW3kin
via health&fitness

Aucun commentaire:

Enregistrer un commentaire